Key facts
- Jyoti and Bharat Patel are participating in an NHS trial using sensors to monitor dementia patients at home.
- The trial uses smart beds, motion sensors, and smart socks/watches to track patient movements, habits, and vital signs.
- Data from the sensors is sent to a team of clinical specialists to monitor daily routines and identify early health changes.
- The technology aims to help patients maintain independence for longer and reduce preventable hospital trips.
- The estimated annual cost is around £2,000 per patient, comparable to a few weeks in a care home.
- None of the devices record sound or video to protect privacy.
A trial involving over 250 families in the UK is exploring the use of advanced technology, including smart beds and motion sensors, to help individuals with dementia live safely in their own homes. The initiative, led by the UK Dementia Research Institute (UK DRI) in partnership with Imperial College London and funded by LifeArc, aims to provide peace of mind to families and enable earlier intervention by healthcare professionals.
Jyoti Patel, who was diagnosed with Alzheimer's in 2021, and her husband Bharat are among the participants. Their home is equipped with various internet-connected sensors that monitor movements, detect falls, check appliance usage to ensure routine adherence, and track sleep disturbances, heart rate, and breathing. Smart socks and a special watch are also being tested to monitor body temperature and gait changes.
The data collected is analyzed by a dedicated team of doctors, nurses, and clinical specialists to understand the patient's daily routine, identify early signs of changing health needs, and help maintain independence. The technology is designed to alert care staff to potential issues before they escalate into a crisis. Privacy is maintained as none of the devices record sound or video.
While the estimated annual cost of approximately £2,000 per patient is significant, Sarah Daniels, health and social care lead at the UK DRI, notes it is comparable to the cost of a few weeks in a care home. She emphasizes that the primary benefit is enabling earlier intervention. NHS England is closely monitoring the trial, with Dr. Jeremy Isaacs, national clinical director for dementia and older people's mental health, stating that the research aligns with existing NHS programs supporting independent living. Bharat Patel expressed that the sensors provide him with greater peace of mind, even a small reduction in worry being beneficial.